CCL2 and Zika virus infectious disease: Our results suggest that in vivo ZIKV infection of CD16+ non-classical monocytes may lead to the production of inflammatory cytokines or chemokines, such as MCP-1, that may promote recruitment of more cellular targets and increased ZIKV dissemination and/or persistence.